LAT and nonpapillary renal cell carcinoma: By obtaining the methylation degree of LAT, HOXD3, and NFE2L3 in ccRCC samples, we could calculate whether the patient was in a high-risk or low-risk state and predict his or her five-year survival rate, as a consideration for targeted treatment.